OrganiGram Holdings (OGI)
NASDAQ:OGI
OGIOrganiGram Holdings
$2.46
-$0.12 (-4.65%)

OrganiGram Holdings Stock Analysis & Ratings

OrganiGram Holdings Stock Analysis Overview

Smart Score
5
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The OrganiGram Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

OGI

OGI Stock Stats

Previous Close$2.58
Open$2.56
Bid2.42 x 200
Ask2.6 x 100
Today’s Range$2.41 - $2.58
52-Week Range$1.01 - $6.45
Volume5.04M
Average Volume7.66M
Market Cap$734.98M
Beta0.90
P/E RatioN/A
EPS-0.67
Earnings DateDec 22, 2021

Company Description

OrganiGram Holdings

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. Its products include strains, cannabis oils, and vaporizrs. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Sector
Basic Materials
Industry
Drug Manufacturers
CEO
Greg Engel
Employees
693
Address
35 English Drive, Moncton, NB, E1E 3X3, CA

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

OrganiGram Holdings News


OGI FAQ

What was OrganiGram Holdings’s price range in the past 12 months?
OrganiGram Holdings lowest stock price was $1.01 and its highest was $6.45 in the past 12 months.
    What is OrganiGram Holdings’s market cap?
    OrganiGram Holdings’s market cap is $734.98M.
      What is OrganiGram Holdings’s price target?
      The average price target for OrganiGram Holdings is $3.72. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $5.00 ,the lowest forecast is $2.98. The average price target represents 51.22% Increase from the current price of $2.46.
        What do analysts say about OrganiGram Holdings?
        OrganiGram Holdings’s analyst rating consensus is a ‘Hold. This is based on the ratings of 4 Wall Streets Analysts.
          When is OrganiGram Holdings’s upcoming earnings report date?
          OrganiGram Holdings’s upcoming earnings report date is Dec 22, 2021 which is in 5 months.
            How were OrganiGram Holdings’s earnings last quarter?
            OrganiGram Holdings released its earnings results on Jul 13, 2021. The company reported -$0.011 earnings per share for the quarter, beating the consensus estimate of -$0.029 by $0.017.
              Is OrganiGram Holdings overvalued?
              According to Wall Street analysts OrganiGram Holdings’s price is currently Undervalued.
                Does OrganiGram Holdings pay dividends?
                OrganiGram Holdings does not currently pay dividends.
                What is OrganiGram Holdings’s EPS estimate?
                OrganiGram Holdings’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does OrganiGram Holdings have?
                OrganiGram Holdings has 298,770,000 shares outstanding.
                  What happened to OrganiGram Holdings’s price movement after its last earnings report?
                  OrganiGram Holdings reported an EPS of -$0.011 in its last earnings report, beating expectations of -$0.029. Following the earnings report the stock price went down -0.377%.
                    Which hedge fund is a major shareholder of OrganiGram Holdings?
                    Currently, no hedge funds are holding shares in OGI

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis